Medico-Legal Update

Abdulridha Mohammed Al-Asady ¹, Farah A. Al-marzook ², Thoalffakar A. ALhamed ¹

Affiliations
1 Assist.Lecturer, College of Nursing, University of Warith Al-anbiya’a, IQ
2 Lecturer, College of Nursing, University of Warith Al-anbiya’a, IQ

Abstract

Diabetes Mellitus (DM) is a collection of metabolic diseases categorized by hyperglycemia caused by insulin excretion deficiencies, insulin performance, or both DM are categorized into distinct kinds. Type 1 diabetes (T1D) is defined by breakdown of β-cells, generally resulting in complete insulin deficiency. Type 2 diabetes (T2D) is a consequence of peripheral tissue insulin resistance. a complete of fifty patients and fifty control subjects were collected between February to October 2018. The genotyping of catalase were attained consuming polymerase chain reaction (PCR) in addition to restriction fragment length polymorphism (RFLP). We tend to firm vigorous changes within the genotype occurrences of catalase between patients with diabetes and controls using the P=0.038, OR =0.58 (0.48-0.78).

Keywords

Diabetes, RFLP, catalase, SNPs. Polymorphisms

Full Text